Herbal approaches to gastrointestinal disorders: Integrating tradition and science

Gastrointestinal (GI) disorders—including IBS, IBD, GERD, peptic ulcers, and constipation—affect a large portion of the global population and impose significant healthcare burdens. Conventional treatments often provide only symptomatic relief and carry risks of adverse effects, resistance, and long-term safety concerns. This has renewed interest in natural products and traditional medicine systems, which offer holistic approaches targeting underlying causes.

Traditional Systems of Medicine

• Ayurveda: GI health is governed by Agni (digestive fire) and the three Doshas. Key formulations include Triphala (laxative, antioxidant, microbiota-modulating) and Avipattikar Churna (for hyperacidity and constipation).

• Traditional Chinese Medicine (TCM): Emphasizes Qi flow and balance of Yin-Yang. Herbs like licorice, ginger, and Baikal skullcap are used to soothe the stomach and reduce inflammation.

• Unani and Siddha: Based on humoral theories. Unani uses ginger, licorice, and senna; Siddha employs formulations like Triphala Choonaranam and Milagu Choonaranam for digestive health.

• Folk medicine: Plants like neem, bael, and castor are used across cultures, reflecting rich ethnopharmacological knowledge.

Classification of Natural Products

• Laxatives/carminatives: Psyllium, senna, fennel, anise.

• Antiemetics/antispasmodics: Ginger, peppermint oil.

• Anti-inflammatory/mucosal protectants: Curcumin, licorice, chamomile.

• Antidiarrheals: Tannin-rich plants (Terminalia, pomegranate).

• Antimicrobials/prebiotics: Garlic, berberine-containing plants, inulin.

Key Bioactive Compounds and Mechanisms

• Anti-inflammatory: Oridonin, triptolide, galangin, engeletin suppress NF-κB and pro-inflammatory cytokines; enhance tight junction proteins.

• Antioxidant: Galangin, canolol, chlorogenic acid reduce oxidative stress and enhance antioxidant enzymes.

• Microbiota modulation: Berberine, chlorogenic acid, ganoderic acid, and costunolide reshape gut microbiota, increase beneficial bacteria, and enhance short-chain fatty acid production.

• Other mechanisms: Gut-brain axis modulation, immunomodulation, epithelial regeneration, motility regulation, and antimicrobial effects.

Clinical Evidence

• Cassia alata: Improved constipation (83% bowel movement within 24h).

• Chinese herbal medicine: Improved IBS symptoms and quality of life.

• Ayurvedic formulation (Aegle marmelos + Bacopa monnieri): 64.9% effectiveness in IBS.

• Padma-179: Improved symptoms in constipation-predominant IBS.

• Turmeric: 87% response rate in functional dyspepsia.

• Mastic gum: 80% symptom relief and 70% ulcer healing in duodenal ulcer.

• Curcumin and peppermint oil: Supported by multiple RCTs and meta-analyses for IBS.

• STW 5 (Iberogast): Effective in IBS and functional dyspepsia.

Safety Considerations

• Pregnancy: Ginger and peppermint relatively safe; licorice contraindicated; Triphala lacks safety data.

• Pediatrics: Peppermint oil, psyllium, and fennel used cautiously; limited dosing guidelines.

• Herb-drug interactions: St. John’s Wort reduces PPI efficacy; curcumin and berberine may increase toxicity of warfarin and statins.

• Contamination: Heavy metals, pesticides, and adulterants reported; quality control essential.

Regulatory and Quality Control
Standardization remains a challenge due to batch variability, chemical instability, and inconsistent labeling. Regulatory frameworks vary: U.S. (DSHEA, dietary supplements), India (AYUSH, GMP, pharmacopoeias), Europe (EMA traditional use registration). Advanced analytical tools (HPLC, DNA barcoding, NMR) and post-market surveillance are critical.

Challenges and Future Directions

• Integrative practice: Growing adoption of herbal interventions in hospitals and clinics, supported by WHO’s Traditional Medicine Strategy.

• Nanotechnology: Nano-encapsulation, liposomes, and phytosomes improve bioavailability and targeted delivery.

• Omics technologies: Metagenomics, metabolomics, and transcriptomics elucidate mechanisms and host-microbe interactions.

• Artificial intelligence: AI accelerates drug discovery, toxicity prediction, and compound-target mapping.

• Personalized medicine: Ayurgenomics integrates Ayurvedic constitution with genomics for tailored interventions.

Conclusions
Herbal medicines offer significant therapeutic potential for GI disorders through anti-inflammatory, antioxidant, microbiota-modulating, and mucosal-protective mechanisms. Traditional systems provide holistic frameworks that align with integrative medicine. Despite challenges in standardization and safety, advances in nanotechnology, omics, AI, and personalized approaches are paving the way for evidence-based integration. Bridging traditional wisdom with modern science positions herbal therapeutics as valuable components of comprehensive GI care.

Full text

https://www.xiahepublishing.com/2994-8754/JTG-2025-00030

The study was recently published in the Journal of Translational Gastroenterology.

Journal of Translational Gastroenterology (JTG) dedicates to improving clinical diagnosis and treatment, advancing understanding of the molecular mechanisms, and promoting translation from bench to bedside of gastrointestinal, hepatobiliary, and pancreatic diseases. The aim of JTG is to provide a forum for the exchange of ideas and concepts on basic, translational, and clinical aspects of gastroenterology, and promote cross-disciplinary research and collaboration.

Follow us on X: @xiahepublishing

Follow us on LinkedIn: Xia & He Publishing Inc.